Maria Ekholm

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

Icro Meattini, Carlotta Becherini, Saverio Caini et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up

Christine Lundgren, Pär‐Ola Bendahl, Maria Ekholm et al. · Breast Cancer Research · 2020 · 74 citations · Full text

Medicine, Immunology, Oncology +14

Two Years of Adjuvant Tamoxifen Provides a Survival Benefit Compared With No Systemic Treatment in Premenopausal Patients With Primary Breast Cancer: Long-Term Follow-Up (> 25 years) of the Phase III SBII:2pre Trial

Maria Ekholm, Pär‐Ola Bendahl, Mårten Fernö et al. · Journal of Clinical Oncology · 2016 · 56 citations · Full text

Medicine, Oncology, Breast Oncology +16

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

Christine Lundgren, Pär‐Ola Bendahl, Åke Borg et al. · Breast Cancer Research and Treatment · 2019 · 32 citations · Full text

Medicine, Oncology, Pathology +17

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

Maria Ekholm, Pär‐Ola Bendahl, Mårten Fernö et al. · European Journal of Cancer · 2019 · 29 citations · Full text

Medicine, Oncology, Breast Oncology +14